IMANIB 400

Manufacturer
INTAS
Packaging
Strip
Composition
IMATINIB TABLETS IP 400MG
Availability
OTC
SKU
PROD-00808

Product Description

๐Ÿ”น Product Overview
IMANIB 400 mg Tablet is a prescription anti-cancer medicine containing Imatinib Mesylate 400 mg as its active ingredient. It belongs to the class of tyrosine kinase inhibitors (TKIs) and is used for the treatment of certain types of cancers, especially blood cancers and gastrointestinal stromal tumors (GIST).
IMANIB works by targeting specific abnormal proteins responsible for uncontrolled cancer cell growth. By blocking these signals, it helps slow down or stop the multiplication of cancer cells.

๐Ÿ”น Key Uses
IMANIB 400 mg Tablet may be prescribed for:
Chronic myeloid leukemia (CML)
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
Gastrointestinal stromal tumors (GIST)
Dermatofibrosarcoma protuberans (DFSP)
Certain bone marrow disorders such as aggressive systemic mastocytosis
(1mg.com)

๐Ÿ”น Composition
Active Ingredient:
Imatinib Mesylate 400 mg
Drug Class:
Tyrosine Kinase Inhibitor (TKI)
Targeted Cancer Therapy
Dosage Form:
Oral Tablet
Therapeutic Category:
Oncology Medicine
Antineoplastic Agent

๐Ÿ”น How It Works
IMANIB contains Imatinib, which works by blocking specific enzymes involved in cancer cell growth.
Mechanism of action:
Inhibits abnormal tyrosine kinase proteins such as BCR-ABL
Blocks signals that promote cancer cell division
Reduces growth and spread of abnormal cells
Helps control progression of certain cancers
This targeted approach helps manage cancers driven by these specific molecular pathways.

๐Ÿ”น Key Benefits
Targeted therapy for specific cancers
Helps control abnormal cancer cell growth
Used in chronic myeloid leukemia treatment
Helps manage gastrointestinal stromal tumors
Oral tablet formulation for convenient administration
Supports long-term disease control when prescribed appropriately

๐Ÿ”น Dosage and Administration
Take IMANIB 400 mg only as prescribed by an oncologist or specialist.
Swallow the tablet whole with water.
It is generally taken with food to reduce stomach discomfort.
Take the medicine at the same time each day.
Do not stop treatment without consulting your doctor, even if symptoms improve.
Dosage may vary depending on:
Type of cancer
Disease stage
Treatment response
Other medicines being used
Patientโ€™s overall health condition

๐Ÿ”น Possible Side Effects
Common side effects may include:
Nausea
Vomiting
Diarrhea
Abdominal discomfort
Muscle cramps
Joint or bone pain
Skin rash
Fatigue
Swelling (edema)
Weight gain
Serious side effects may include:
Low blood cell counts
Severe infections
Liver function changes
Severe skin reactions
Unusual bleeding or bruising
Breathing difficulties
Seek medical advice if severe or persistent symptoms occur.

๐Ÿ”น Precautions
Before taking IMANIB 400 mg, inform your doctor if you have:
Liver disease
Kidney problems
Heart conditions
Bleeding disorders
History of allergic reactions to Imatinib
Pregnancy or breastfeeding status
Important precautions:
Regular blood tests may be required to monitor blood counts and liver function.
Avoid grapefruit juice unless approved by your doctor.
Inform your doctor about all medicines, supplements, and herbal products.
Do not share this medicine with others.

Additional Information

  • Category: category change
  • Manufacturer: INTAS
  • Packaging: Strip
  • Composition: IMATINIB TABLETS IP 400MG
  • Storage: Store in a cool, dry place away from direct sunlight
  • Shelf Life: As per manufacturer's guidelines
  • Prescription Status: Over-the-Counter (OTC)

How to Use

Important: Always follow your healthcare provider's instructions when using this medication.

  • Take this medicine as directed by your physician
  • Do not exceed the recommended dosage
  • Complete the full course of treatment even if symptoms improve
  • Store the medication properly as per storage instructions
  • Keep out of reach of children
  • Check expiry date before use

Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.